Your browser doesn't support javascript.
loading
Serum-based measurements of stromal activation through ADAM12 associate with poor prognosis in colorectal cancer.
Ten Hoorn, Sanne; Waasdorp, Cynthia; van Oijen, Martijn G H; Damhofer, Helene; Trinh, Anne; Zhao, Lan; Smits, Lisanne J H; Bootsma, Sanne; van Pelt, Gabi W; Mesker, Wilma E; Mol, Linda; Goey, Kaitlyn K H; Koopman, Miriam; Medema, Jan Paul; Tuynman, Jurriaan B; Zlobec, Inti; Punt, Cornelis J A; Vermeulen, Louis; Bijlsma, Maarten F.
Afiliação
  • Ten Hoorn S; Amsterdam UMC location University of Amsterdam, Center for Experimental and Molecular Medicine, Laboratory for Experimental Oncology and Radiobiology, Cancer Center Amsterdam, Imaging and Biomarkers, Meibergdreef 9, Amsterdam, the Netherlands.
  • Waasdorp C; Cancer Center Amsterdam, Imaging and Biomarkers, Amsterdam, the Netherlands.
  • van Oijen MGH; Oncode Institute, Amsterdam, The Netherlands.
  • Damhofer H; Amsterdam UMC location University of Amsterdam, Center for Experimental and Molecular Medicine, Laboratory for Experimental Oncology and Radiobiology, Cancer Center Amsterdam, Imaging and Biomarkers, Meibergdreef 9, Amsterdam, the Netherlands.
  • Trinh A; Cancer Center Amsterdam, Imaging and Biomarkers, Amsterdam, the Netherlands.
  • Zhao L; Oncode Institute, Amsterdam, The Netherlands.
  • Smits LJH; Amsterdam UMC location University of Amsterdam, Department of Medical Oncology, Cancer Center Amsterdam, Meibergdreef 9, Amsterdam, The Netherlands.
  • Bootsma S; Amsterdam UMC location University of Amsterdam, Center for Experimental and Molecular Medicine, Laboratory for Experimental Oncology and Radiobiology, Cancer Center Amsterdam, Imaging and Biomarkers, Meibergdreef 9, Amsterdam, the Netherlands.
  • van Pelt GW; Cancer Center Amsterdam, Imaging and Biomarkers, Amsterdam, the Netherlands.
  • Mesker WE; Cell Biology Program, Memorial Sloan Kettering Cancer Center, New York, USA.
  • Mol L; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, USA.
  • Goey KKH; Department of Electronic Engineering, City University of Hong Kong, Kowloon, Hong Kong.
  • Koopman M; Amsterdam UMC location Vrije Universiteit Amsterdam, Department of Surgery, Cancer Center Amsterdam, Boelelaan 1117, Amsterdam, the Netherlands.
  • Medema JP; Amsterdam UMC location University of Amsterdam, Center for Experimental and Molecular Medicine, Laboratory for Experimental Oncology and Radiobiology, Cancer Center Amsterdam, Imaging and Biomarkers, Meibergdreef 9, Amsterdam, the Netherlands.
  • Tuynman JB; Cancer Center Amsterdam, Imaging and Biomarkers, Amsterdam, the Netherlands.
  • Zlobec I; Oncode Institute, Amsterdam, The Netherlands.
  • Punt CJA; Department of Surgery, Leiden University Medical Center, Leiden, The Netherlands.
  • Vermeulen L; Department of Surgery, Leiden University Medical Center, Leiden, The Netherlands.
  • Bijlsma MF; Department of Data Management, Netherlands Comprehensive Cancer Center (IKNL), Nijmegen, The Netherlands.
BMC Cancer ; 22(1): 394, 2022 Apr 12.
Article em En | MEDLINE | ID: mdl-35413826

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Retais / Neoplasias Colorretais / Neoplasias do Colo / Fibroblastos Associados a Câncer Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: BMC Cancer Assunto da revista: NEOPLASIAS Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Holanda

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Retais / Neoplasias Colorretais / Neoplasias do Colo / Fibroblastos Associados a Câncer Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: BMC Cancer Assunto da revista: NEOPLASIAS Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Holanda